CAJ | 학술논문

目的：分析静脉溶栓治疗急性心肌梗死的临床疗效。方法在我院住院的107例心肌梗死患者进行回顾性比较，其中56例使用瑞替普酶静脉溶栓的作为治疗组，51例常规治疗的作为对照组，比较两组病人心脏梗死血管的再通率、并发症发生率和死亡率。结果治疗组血管再通率比对照组明显增高，而并发症发生率和死亡率比对照组明显降低，差异有统计学意义(P<0.05)。结论应用瑞替普酶进行静脉溶栓治疗急性心肌梗死可提高梗塞血管再通率和降低病人死亡率，是值得广大基层医生推广的治疗方法。
목적：분석정맥용전치료급성심기경사적림상료효。방법재아원주원적107례심기경사환자진행회고성비교，기중56례사용서체보매정맥용전적작위치료조，51례상규치료적작위대조조，비교량조병인심장경사혈관적재통솔、병발증발생솔화사망솔。결과치료조혈관재통솔비대조조명현증고，이병발증발생솔화사망솔비대조조명현강저，차이유통계학의의(P<0.05)。결론응용서체보매진행정맥용전치료급성심기경사가제고경새혈관재통솔화강저병인사망솔，시치득엄대기층의생추엄적치료방법。
Objective To analyze the clinical efficacy of intravenous thrombolytic therapy for acute myocardial infarction. Methods One hundred and seven patients with myocardial infarction who were hospitalized at our hospital were retrospectively analyzed. The patients were divided into treatment group, which received reteplase -based intravenous thrombolysis (n=56), and control group, which underwent conventional treatment (n=51). The recanalization rate, complication rate, and mortality rate were compared between the two groups. Results The treatment group had a significantly higher recanalization rate and significantly lower complication rate and mortality rate than the control group (P<0.05). Conclusion The use of reteplase-based intravenous thrombolysis for treatment of acute myocardial infarction can enhance the recanalization of clogged blood vessels and reduce mortality, providing an effective treatment option for physicians at primary hospitals.